Literature DB >> 9514056

Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype.

S Hietanen1, K Syrjänen, S Syrjänen.   

Abstract

Two cell lines derived from vaginal intraepithelial neoplasias (VAINs) expressing human papillomavirus (HPV) 33 (VAIN I, UT-DEC-1) and 16 (VAIN II, UT-DEC-2) E6-E7 mRNA were studied in organotypic culture for their keratins and cell cycle regulatory proteins in relation to replicative aging. Early-passage UT-DEC-1 and UT-DEC-2 cells reproduced epithelial patterns consistent with VAIN. Cells from later passages resembled full-thickness intraepithelial neoplasia (UT-DEC-1) and microinvasive cancer (UT-DEC-2). The morphological changes were compatible with these cell lines' ability for anchorage-independent growth at later passages. Simple epithelial keratins were aberrantly expressed in both cell lines. K18 (absent in normal vaginal keratinocytes) and K17 expression increased in UT-DEC-1 and UT-DEC-2 cells at late passages. No marked differences in expression of p53 (wild type in both cell lines), mdm-2 or PCNA were detected in parallel with progression. The expression of p21WAF1/cip1 localized mostly to the upper half of the epithelium at early passage and was more intense in the HPV 16-positive UT-DEC-2 cell line expressing K10. In Northern blot analyses, the transcription pattern of the HPV 33 E6-E7 of the UT-DEC-1 cell line changed during later passages, whereas that of the HPV 16 E6-E7 of the UT-DEC-2 cell line remained unaltered. The present characterization of the phenotype of these cell lines derived from natural squamous intraepithelial lesions shows an association between simple epithelial-type keratin expression and progressive changes in growth and morphology, but fails to demonstrate consistent changes in the expression of cell cycle regulatory proteins studied in parallel with progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514056      PMCID: PMC2149962          DOI: 10.1038/bjc.1998.125

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  45 in total

1.  p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6.

Authors:  M Molinari; J Milner
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

2.  p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.

Authors:  A Marchetti; C Doglioni; M Barbareschi; F Buttitta; S Pellegrini; G Bertacca; A Chella; G Merlo; C A Angeletti; P Dalla Palma; G Bevilacqua
Journal:  Oncogene       Date:  1996-03-21       Impact factor: 9.867

3.  Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes.

Authors:  S Cheng; D C Schmidt-Grimminger; T Murant; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1995-10-01       Impact factor: 11.361

4.  Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.

Authors:  S H Hietanen; K Kurvinen; K Syrjänen; S Grénman; T Carey; K McClatchey; S Syrjänen
Journal:  Am J Obstet Gynecol       Date:  1995-11       Impact factor: 8.661

5.  p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.

Authors:  K Kurvinen; K Syrjänen; S Syrjänen
Journal:  J Clin Oncol       Date:  1996-07       Impact factor: 44.544

6.  Interaction between the retinoblastoma protein and the oncoprotein MDM2.

Authors:  Z X Xiao; J Chen; A J Levine; N Modjtahedi; J Xing; W R Sellers; D M Livingston
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

7.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

8.  p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.

Authors:  H Ikenberg; K Matthay; B Schmitt; T Bauknecht; M Kiechle-Schwarz; A Göppinger; A Pfleiderer
Journal:  Cancer       Date:  1995-07-01       Impact factor: 6.860

9.  Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.

Authors:  C Missero; E Calautti; R Eckner; J Chin; L H Tsai; D M Livingston; G P Dotto
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.

Authors:  S B Parker; G Eichele; P Zhang; A Rawls; A T Sands; A Bradley; E N Olson; J W Harper; S J Elledge
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

View more
  2 in total

1.  Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas.

Authors:  N Johansson; M Vaalamo; S Grénman; S Hietanen; P Klemi; U Saarialho-Kere; V M Kähäri
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

2.  17β-estradiol and progesterone effect on human papillomavirus 16 positive cells grown as spheroid co-cultures.

Authors:  Merja Ruutu; Jaana Rautava; Aaro Turunen; Teemu Tirri; Stina Syrjänen
Journal:  Cytotechnology       Date:  2017-10-05       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.